RMD is meeting the need for new biosensors for medical diagnostic and to fight bioterrorism.  RMD is developing a high sensitivity assay platform based upon magnetic nanoparticles and the phenomenon of optical birefringence with the ability to produce high affinity assay reagents using our bivalent aptamer technology.

These platforms include:

RMD is developing biosensors and biosensor platforms.